Ionis Pharmaceuticals

$51.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.89 (+1.77%) Today

$0.00 (0.00%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell IONS and other stocks, options, and ETFs commission-free!

About IONS

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA. The listed name for IONS is Ionis Pharmaceuticals, Inc. Common Stock.

CEO

Brett P. Monia

Employees

817

Headquarters

Carlsbad, California

Founded

1989

Market Cap

7.15B

Price-Earnings Ratio

126.56

Dividend Yield

—

Average Volume

728.70K

High Today

$51.19

Low Today

$50.01

Open Price

$50.16

Volume

415.88K

52 Week High

$66.22

52 Week Low

$39.32

Collections

Analyst Ratings

43%

of 23 ratings

Buy

43%

Hold

39%

Sell

17%

IONS Earnings

-$0.35

$0.21

$0.77

$1.33

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 24, Pre-Market